| Discovery and mechanistic study of tailor-made quinoline derivatives as topoisomerase 1 poison with potent anticancer activity B Kundu, SK Das, S Paul Chowdhuri, S Pal, D Sarkar, A Ghosh, ... Journal of Medicinal Chemistry 62 (7), 3428-3446, 2019 | 56 | 2019 |
| Topoisomerase I inhibitors: Challenges, progress and the road ahead A Talukdar, B Kundu, D Sarkar, S Goon, MA Mondal European Journal of Medicinal Chemistry 236, 114304, 2022 | 50 | 2022 |
| Understanding the riboflavin biosynthesis pathway for the development of antimicrobial agents B Kundu, D Sarkar, N Ray, A Talukdar Medicinal research reviews 39 (4), 1338-1371, 2019 | 21 | 2019 |
| Development of a metabolically stable topoisomerase I poison as anticancer agent B Kundu, D Sarkar, SP Chowdhuri, S Pal, SK Das, BB Das, A Talukdar European Journal of Medicinal Chemistry 202, 112551, 2020 | 9 | 2020 |
| Discovery and Development of Quinazolinones and Quinazolinediones for Ameliorating Nonalcoholic Fatty Liver Disease (NAFLD) by Modulating COP1-ATGL Axis D Sarkar, S Chowdhury, S Goon, A Sen, UG Dastidar, MA Mondal, ... Journal of Medicinal Chemistry 66 (24), 16728-16761, 2023 | 3 | 2023 |
| Bicycle topoisomerase I inhibiting compounds, process for preparation and use thereof A Talukdar, BB Das, B Kundu, CS PAUL, D SARKAR, S Pal, ... US Patent App. 17/059,289, 2021 | 2 | 2021 |
| Bromhexine: Into the spotlight A Talukdar, D Sarkar, D Sarkar Viral, Parasitic, Bacterial, and Fungal Infections, 719-731, 2023 | 1 | 2023 |
| Catalyzing the Future of Medicinal Chemistry Research in India A Talukdar, D Sarkar Journal of Medicinal Chemistry 66 (16), 10868-10877, 2023 | | 2023 |
| A PREPARATION OF QUINAZOLINEDIONES AND USE THEREOF HI Talukdar Arindam, Chakrabarti Partha, Sarkar Dipayan, Chowdhury Saheli ... | | 2023 |
| QUINAZOLINONES DERIVATIVES FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE, PREPARATION AND USE THEREOF SD TALUKDAR Arindam, CHAKRABARTI Partha, SARKAR Dipayan, CHOWDHURY Saheli ... WO Patent WO2,022,003,712, 2022 | | 2022 |
| Protective role of ACE inhibitors and ARBs in hypertensive patients suffering from COVID-19 A Talukdar, D Sarkar, S Roychowdhury, D Ganguly Authorea Preprints, 2020 | | 2020 |
| Small molecule ACSS2 inhibitors target acetate metabolizing tumor cells in hypoxic conditions M Banerjee, S Basu, D Chakraborty, R Shrivastava, S Middya, R Ghosh, ... Cancer Research 78 (13_Supplement), 3510-3510, 2018 | | 2018 |
